New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
Laboratory Industry Report
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Subscribe today for access to
Articles and Reports
How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Already a member? Log in here
FDA Watch: Natera, Valar Labs Receive FDA Clearances for Bladder Cancer Tests
Natera’s assay focuses on the need for adjuvant therapy, while Valar’s test stratifies risk of recurrence
Already a member? Log in here
Cancer Genetics, Mayo Clinic Form Joint Venture
...
Already a member? Log in here
Aetna Cutting Lab Rates Well Below Medicare
...
Already a member? Log in here
Industry Buzz: Bio-Reference Subsidiary Strikes Deal With Big Oncology Group
...
Already a member? Log in here
Quest, Hologic Align With Focus on Women’s Health
...
Already a member? Log in here
The Myriad Supreme Court Decision: A Win-Win-Win?
...
Already a member? Log in here
OIG Recommends Medicare Payment Cuts
...
Already a member? Log in here
Industry Buzz: More Labs Offering BRCA Testing
...
Already a member? Log in here
Lab Stocks Gain 6.2 Percent During First Half of Year
...
Already a member? Log in here